← 文档中心 / Hub
机密 · 上市战略决策 · CONFIDENTIAL · IPO STRATEGY
DIRECT vs FRANCHISE · IPO STRATEGIC IMPACT · BILINGUAL

直营 vs 加盟 · Direct vs Franchise

哪种模式对泽瑞 IPO 成功更有利? Which model favors Zerui's IPO success?
编制 / By:道纳科技战略组 · v1.0 · 2026.07.14 · 目标 / Target:港交所主板 vs A 股科创板双路径
LANGUAGE 语言

1核心命题 / Core Thesis

中文

问题:泽瑞规划 24 个月扩张至 50 家直营 + 1000 家加盟。这个"直营 : 加盟 = 5 : 100"的比例,对 IPO 成功究竟是加分还是减分?如果重新设计,哪种模式更有利?

ENGLISH

Question: Zerui plans to expand to 50 direct-operated + 1,000 franchised stores in 24 months. Does this 5:100 ratio favor or hurt IPO success? If redesigned, which model works better?

ONE-LINER VERDICT · 一句话结论
"混合模式"最优 · 但比例按上市地反向调整
"Hybrid" is optimal · Ratio flips by exchange
目标 港交所主板:加盟为主(80%+)· 港股喜爱加盟"平台+SaaS"叙事,蜜雪冰城/古茗/名创优品都是成功先例
目标 A 股科创板:直营为主(60%+)· A 股对加盟合规审核极严,直营公司更容易过会
泽瑞现状 5:100 = 极度倾向加盟,若冲 A 股需大幅调整;若冲港股则保持即可
Target HKEX Main Board: Franchise-heavy (80%+) · HK loves "platform+SaaS" narrative — Mixue, Guming, Miniso are proven cases
Target A-share STAR Market: Direct-heavy (60%+) · A-share regulator scrutinizes franchise deeply, direct model passes easier
Zerui's current 5:100 = franchise-dominant. Keep for HK · Overhaul for A-share

2模式对比 · 全维度矩阵 / Full-Dimension Comparison

维度 / Dimension直营 / Direct加盟 / FranchiseIPO 影响 / IPO Impact
收入确认 / Revenue门店 100% GMV / 100% store GMV加盟费+品牌费+供货毛利 / fees + royalty + supply margin直营营收更"漂亮" / Direct = better top-line
毛利率 / Gross60-70%60-75%加盟略高 / Franchise slightly higher
净利率 / Net Margin20-30%40-60%(轻资产 / asset-light)加盟更高 / Franchise wins
CapEx 强度60 万/店 · 高 / RMB 600K/store · high近 0(加盟商投入)/ Near-zero (franchisee funded)加盟更轻 / Franchise lighter
ROE15-25%30-50%加盟更高 / Franchise wins
扩张速度 / Speed1-2 年建 50 家 / 50 stores in 1-2 yr2 年建 500-1000 家 / 500-1K in 2 yr加盟更快 / Franchise faster
标准化控制 / Standardization强 / Strong (HQ direct)弱 / Weak (SOP-based)直营更稳 / Direct more stable
数据真实性 / Data FidelityPOS+银行+CRM 三方核验 / three-way verified加盟商上报 / Franchisee-reported直营更可信 / Direct more credible
关联交易风险 / Related-party risk无 / None关联加盟商需披露 / Related franchisees must disclose直营无风险 / Direct no risk
估值 P/E / Multiple15-25x (retail chain)25-40x (platform)加盟更高 (HK) / Franchise wins on HK
抗周期 / Recession-proof房租人力刚性 / Rigid opex轻资产抗风险 / Asset-light加盟略优 / Franchise slight edge
会员数据资产 / Data ownership100% 归总部 / 100% HQ-owned需 SaaS 强制回传 / SaaS-forced upload直营更完整 / Direct more complete
直营的核心优势 / Direct's Core Wins
中文

1. 报表可信度:POS + 银行流水 + 会员系统三方交叉核验,Q&A 压力小

2. 无关联交易疑问:不存在"关联加盟商"、"体外循环"等雷点

3. 品牌资产完整:会员数据 100% 归总部,KPI 数据链完整

4. A 股审核友好:直营连锁历史通过率 85%+

ENGLISH

1. Report credibility: Three-way verification of POS + bank + CRM = smooth Q&A

2. No related-party issues: No "related franchisees" or "off-balance-sheet" landmines

3. Complete brand equity: 100% membership data at HQ, full KPI chain

4. A-share friendly: Direct chain 85%+ historical approval rate

加盟的核心优势 / Franchise's Core Wins
中文

1. 极高净利率:轻资产 40-60%,是直营 2-3 倍

2. 平台估值溢价:港/美股给"品牌+SaaS+供应链" 25-40x P/E

3. 现金流预付制:加盟费+供货款预付,OCF 高于净利

4. 增长天花板高:1000-3000 家规模,蜜雪冰城 3.4 万家

ENGLISH

1. High margins: Asset-light 40-60% net, 2-3x direct model

2. Platform premium: HK/US award 25-40x P/E for "brand+SaaS+supply"

3. Prepaid cash flow: Upfront fees + supply prepay, OCF exceeds net income

4. Higher ceiling: 1K-3K stores possible, Mixue reached 34,000

3上市地差异 · 三大交易所对比 / Exchange Comparison

维度 / Dimension港交所主板 / HKEX MainA 股科创板 / STAR Market美股 NASDAQ / NASDAQ
对加盟接受度 / Franchise acceptance✅ 高 / High⚠️ 严格 / Strict✅ 高 / High
审核重点 / Focus areas合同规范 · SaaS · 复购 / Contracts, SaaS, repeat关联加盟 · 真实性专项 / Related parties, authenticity财务透明 · 消保 / Transparency, consumer protection
加盟成功案例 / Franchise IPO wins蜜雪冰城 · 古茗 · 茶百道 / Mixue, Guming, Chapanda较少 / Few (mostly F&B)汉堡王 · 麦当劳 / Burger King, McDonald's
直营成功案例 / Direct IPO wins海底捞 · 呷哺呷哺 / Haidilao, Xiabu广州酒家 · 全聚德 / Guangzhou Restaurant, Quanjude星巴克 · Chipotle
加盟给的 P/E / Franchise P/E25-40x (溢价 / premium)15-25x (常规 / normal)20-35x
直营给的 P/E / Direct P/E15-25x30-50x (科技+ / tech premium)20-30x
审核时长 / Review time12-18 月 / months18-36 月 (加盟延长 / extended)6-12 月 / months
加盟真实性核查 / Franchisee audit抽样 5-10% / sample抽样 20-30% (深度 / deep)抽样 5-10% / sample
关键洞察

· 港交所对加盟"友好"(成熟审核 + 高 P/E 溢价)· A 股对加盟"警惕"(历史多个加盟企业被否)

· 泽瑞加盟 1000 家如冲 A 股,将面临巨大尽调压力(30% 抽样 = 300 家逐一核查)

KEY INSIGHT

· HKEX is franchise-friendly (mature review + P/E premium) · A-share is wary (multiple franchise IPO failures on record)

· If Zerui's 1,000 franchisees go A-share, DD pressure is huge (30% sample = 300 franchises individually verified)

4案例复盘 · 成败经验 / Case Studies

加盟成功案例(港股) / Franchise IPO Wins (HK)

蜜雪冰城 · Mixue Bingcheng(2024 HK IPO)成功 / Success
港交所 / HKEX · 3.4 万家 (99% 加盟) / 34K stores (99% franchise) · 千亿港币市值 / HK$100B+ mkt cap

加盟模式做到极致 · 供应链集采毛利 30% · 加盟费 + 供货费双重现金流 · 港股给 30x P/EFranchise perfected · 30% supply margin · Dual revenue (fees + supply) · HK awarded 30x P/E

对泽瑞启示 / Lesson加盟规模化 + 供应链集采是港股喜欢的组合(泽瑞正是这个路径)Scaled franchise + supply chain integration = HK's favorite combo (Zerui's exact path)

古茗 · Guming(2025 HK IPO)成功 / Success
港交所 / HKEX · 9000 家 100% 加盟 / 9,000 stores 100% franchise

全加盟模式,通过 SaaS 系统实时追踪门店销售 · 加盟商赋能体系完善100% franchise, real-time SaaS store tracking, franchisee empowerment system

对泽瑞启示 / LessonSaaS 数据可信性是加盟企业港股 IPO 的核心(Elyworld 平台正好承担这个角色)SaaS data credibility is the core for franchise HK-IPO (Elyworld platform serves this role)

锅圈食汇 · Guoquan Shihui(2023 HK IPO)成功 / Success
港交所 / HKEX · 1 万家 99% 加盟 / 10K stores 99% franchise

加盟制打法:预付款+供货费+SaaS · 港股上市 12 个月完成Franchise playbook: prepay + supply fee + SaaS · HK IPO in 12 months

加盟受阻案例 / Franchise IPO Setbacks

巴奴毛肚火锅 · Banu Hotpot波折 / Struggle
拟港股 / Filed HK · 直营为主 / Direct-heavy

直营为主的连锁餐饮,扩张速度慢,冲击 IPO 反复 · 3 年未成Direct-heavy F&B chain, slow expansion, repeated IPO attempts · 3 years still pending

对泽瑞启示 / Lesson纯直营的餐饮/零售扩张慢,IPO 增长故事不好讲Pure-direct F&B/retail scales slowly · Growth story struggles

某 A 股拟上市中医连锁 · Anonymous TCM Chain被否 / Rejected
拟 A 股 / Attempted A-share · 50 直营 + 500 加盟 / 50 direct + 500 franchise

被否原因 / Rejection reasons① 关联方加盟商 5% · ② SSSG 数据无法核验 · ③ 抽查 20% 中 3 家虚假开店① 5% related-party franchisees · ② SSSG unverifiable · ③ 3 fake stores in 20% audit sample

对泽瑞启示 / LessonA 股审核对加盟真实性极严,若冲 A 股需全面加盟合规A-share regulator scrutinizes franchise authenticity heavily · Full compliance required

直营成功案例 / Direct IPO Wins

海底捞 · Haidilao(2018 HK IPO)成功 / Success
港交所 / HKEX · 100% 直营 / 100% direct · 千亿港币 / HK$100B+ mkt cap

100% 直营模式,SSSG 数据完整 · 后续市值波动大(重资产劣势)100% direct, clean SSSG data · Post-IPO high volatility (heavy-asset drawback)

星巴克中国 · Starbucks China规划中 / Planning
拟港交所 / HK filing · 8000+ 100% 直营 / 100% direct

百分百直营模式典范 · 但估值面临"增长放缓"质疑100% direct model exemplar · But valuation faces "growth deceleration" concerns

5估值影响 · 泽瑞四方案量化对比 / Valuation Impact — 4 Scenarios

Y5 估值对比 / Y5 Valuation Scenarios

方案 / Scenario直营 / Direct加盟 / FranchiseY5 营收 (亿)/Rev (RMB100M)Y5 净利 (亿)/Net (RMB100M)P/E估值 (亿) / Valuation上市地 / Exchange
A · 现状 / Current5%95%21.35.1225-30x (HK)128-154港交所 / HKEX
B · 平衡 / Balanced30%70%18.53.920-30x78-117双市场 / Either
C · 偏直营 / Direct-heavy60%40%14.02.630-50x (A)78-130A 股科创板 / STAR
D · 纯直营 / Pure Direct100%0%7.51.640-60x (A)64-96A 股科创板 / STAR
关键洞察

· 方案 A(现状):港股估值最高,加盟合规压力中等

· 方案 B(平衡):估值中位,双市场可选,最灵活

· 方案 C(偏直营):A 股科创板估值溢价,但营收规模小

· 方案 D(纯直营):最简单最合规,但增长天花板低

KEY INSIGHT

· Plan A (Current): Highest HK valuation, moderate franchise DD pressure

· Plan B (Balanced): Median valuation, dual-market flexible

· Plan C (Direct-heavy): A-share premium, but smaller revenue

· Plan D (Pure Direct): Simplest & most compliant, low growth ceiling

6审核风险 · 加盟模式六大雷区 / Franchise Model — 6 Regulatory Landmines

中文

加盟模式在 IPO 审核中的六大雷区(尤其 A 股):

  1. 关联方加盟商:董监高及亲属持股加盟店
  2. 体外循环:加盟商通过关联方进货虚增收入
  3. 加盟商真实性:抽样核查发现"虚假门店"
  4. 加盟合同规范性:区域独家、强制搭售、退出条款
  5. SSSG 数据可信度:SaaS 数据能否穿透验证
  6. 加盟商退出率高:报告期内大批关闭
ENGLISH

Six regulatory landmines for franchise IPO (especially A-share):

  1. Related-party franchisees: Directors/execs holding franchise equity
  2. Off-balance-sheet loop: Franchisees buying via related parties
  3. Franchisee authenticity: Sample audit uncovers "ghost stores"
  4. Franchise contract compliance: Exclusivity, tying, exit terms
  5. SSSG data reliability: Can SaaS data withstand scrutiny
  6. High franchisee churn: Mass closures within reporting period

泽瑞的应对 / Zerui's Mitigation

雷区 / Landmine泽瑞现状 / Zerui Status应对方案 / Mitigation
关联方加盟商 / Related franchisees< 3%严格披露 + 公允价格 / Full disclosure + fair pricing
体外循环 / Off-books loop无 / None (public supply chain)四大出具意见 / Big-4 opinion
加盟商真实性 / Authenticity需抽样审计 / Need auditY2 起季度 20% 抽样 / Quarterly 20% from Y2
合同规范性 / Contract compliance金杜/中伦起草 / Drafted by top firms律师意见书年度更新 / Annual legal opinion
SSSG 可信 / SSSG reliabilityElyworld SaaS 强制回传 / Forced SaaS uploadSaaS + POS 交叉核验 / SaaS + POS crossverify
退出率 / Churn rate5 年存活 85% / 85% 5-year survival队列追踪长期披露 / Cohort tracking disclosure
加盟审核额外成本估算 / Extra Franchise Audit Cost
  • 律师费 / Legal: +200-500 万 / RMB 2-5M
  • 审计费 / Audit: +300-800 万 / RMB 3-8M
  • 时间延长 / Time extension: +6-12 月 / months
  • 被否风险 / Rejection risk: +15-25% (A) · +5-10% (HK)

7泽瑞推荐策略 · 分市场分阶段混合模式 / Recommended Strategy — Market-Specific Hybrid

STRATEGIC RECOMMENDATION · 战略建议
港股 Plan A · 保持现状加盟为主 · 首选目标
HK Plan A · Keep franchise-dominant · Primary target
维持"直营 5% + 加盟 95%"结构不变 · 港股对加盟叙事高度友好 + P/E 溢价 + 12-18 月上市周期 · 类比蜜雪 / 古茗 / 锅圈 Maintain "5% direct + 95% franchise" · HK loves franchise narrative + P/E premium + 12-18mo review · Analogous to Mixue / Guming / Guoquan

Plan A · 港交所主板(推荐) / HKEX Main (Recommended)

中文

维持现状加盟为主,重点做三件事:

  1. 加盟合规化专项:Y1 完成金杜律所加盟合同标准化 + 加盟商真实性 SOP
  2. SaaS 数据穿透:Elyworld 平台强制回传所有加盟商 POS 数据
  3. 供应链集采叙事强化:享受 30-40x P/E

预期结果:Y5 递表 · Y6 港交所主板挂牌 · 估值 128-154 亿港币

ENGLISH

Keep franchise-dominant, focus on 3 actions:

  1. Franchise compliance project: Y1 complete contract standardization + authenticity SOP
  2. SaaS data penetration: Elyworld platform forces all franchisee POS uploads
  3. Supply chain narrative amplification: Earn 30-40x P/E

Expected outcome: Y5 filing · Y6 HKEX Main listing · HK$12.8-15.4B valuation

Plan B · A 股科创板(备选) / A-Share STAR (Backup)

中文

如果监管窗口开启 A 股上市:调整为直营为主

  1. 直营比例提升至 60%+:Y3 起加大直营投入
  2. 科技属性放大:太赫兹 + AI + 恒友幸研发
  3. 加盟收缩至战略级:只保留 200-300 家精品加盟

预期结果:Y6-Y7 递表 · Y7-Y8 科创板挂牌 · 估值 130-200 亿人民币

ENGLISH

If regulatory window opens for A-share: shift to direct-dominant

  1. Raise direct to 60%+: Ramp direct investment from Y3
  2. Amplify tech DNA: Terahertz + AI + Hengyouxing R&D
  3. Franchise contract to strategic level: Keep only 200-300 elite stores

Expected outcome: Y6-Y7 filing · Y7-Y8 STAR listing · RMB 13-20B valuation

Plan C · 双重上市 / Dual Listing

Y6 港股 → Y7-Y8 A 股 · H+A 双重挂牌 / HK → then A · Dual Listing

先港股(加盟叙事高估值)→ 再 A 股(科技属性溢价)· 借助已上市地位反向申请 A 股,享受估值提升 40-70% · 对标:药明康德 · 中国生物制药 · 华虹半导体

HK first (franchise narrative premium) → then A-share (tech premium) · Leverage HK-listed status for A-share, unlocking +40-70% valuation lift · Analogous to WuXi AppTec / Sino Biopharm / Hua Hong Semi

8一句话结论 / One-Line Conclusion

中文

泽瑞的"5 直营 + 1000 加盟"是典型港股题材,不是 A 股题材。如果坚持港股主板(推荐),维持现状即可,重点是加盟合规化 + SaaS 数据穿透 + 供应链叙事强化,Y6 挂牌估值 128-154 亿港币。如果转向 A 股科创板(备选),必须在 Y2-Y3 就大幅提高直营比例至 60%+,营收规模会降低但净利率与 P/E 都会更高,最终估值可能相当。最优路径是"H → H+A"双重上市,兼得加盟高估值 + 科技溢价。

ENGLISH

Zerui's "5 direct + 1,000 franchise" is a classic HKEX story, not A-share material. If HK Main is the target (recommended), keep the status quo — focus on franchise compliance + SaaS data penetration + supply chain narrative. Y6 listing at HK$12.8-15.4B valuation. If pivoting to A-share STAR (backup), direct-store share must rise to 60%+ by Y2-Y3, sacrificing revenue but gaining higher net margins & P/E. The optimal path is dual "H → H+A" listing, capturing both franchise-premium (HK) and tech-premium (A-share).

不是"直营 vs 加盟"的对错
而是"哪个市场买单哪种故事"
泽瑞的答案:港股买单加盟 · A 股买单直营
Not "Direct vs Franchise" — rather
"Which market buys which story"
Zerui's answer: HK buys franchise · A-share buys direct

三大关键决策点 / Three Key Decisions

决策 / Decision推荐 / Recommend理由 / Rationale
是否调整直营/加盟比例?
Adjust direct/franchise mix?
不调整(若冲港股)
No (if HK-bound)
现状是港股最佳配置 / Current mix is HK-optimal
是否加大加盟合规投入?
Increase franchise compliance spend?
是(Y1 立即启动)
Yes (start Y1)
合规 = 港股 IPO 通行证 / Compliance = HK IPO passport
是否为 A 股备选保留可能?
Preserve A-share optionality?
是(保持科技属性)
Yes (maintain tech DNA)
研发 6.5% + 高新 + 专精特新 / R&D 6.5% + high-tech cert
免责声明 / Disclaimer本分析为战略框架推演,实际 IPO 路径选择须结合监管窗口、市场估值环境、公司经营实际动态调整。所有数据、估值均为示意,不构成投资、法律或税务意见。This analysis is a strategic framework. Actual IPO path selection must consider regulatory windows, market valuation environment, and operational realities. All figures are illustrative, not investment/legal/tax advice.